These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20230538)

  • 1. Refractory insulin allergy: pancreas transplantation or immunosuppressive therapy alone?
    Léonet J; Malaise J; Squifflet JP
    Transpl Int; 2010 Jul; 23(7):e39-40. PubMed ID: 20230538
    [No Abstract]   [Full Text] [Related]  

  • 2. Omalizumab for drug allergy.
    Matheu V; Franco A; Perez E; Hernández M; Barrios Y
    J Allergy Clin Immunol; 2007 Dec; 120(6):1471-2; author reply 1472-3. PubMed ID: 17854881
    [No Abstract]   [Full Text] [Related]  

  • 3. Rituximab and omalizumab in severe, refractory insulin allergy.
    Yong PF; Malik R; Arif S; Peakman M; Amiel S; Ibrahim MA; Gough A
    N Engl J Med; 2009 Mar; 360(10):1045-7. PubMed ID: 19264698
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful use of omalizumab in an inadequately controlled type 2 diabetic patient with severe insulin allergy.
    Cavelti-Weder C; Muggli B; Keller C; Babians-Brunner A; Biason-Lauber A; Donath MY; Schmid-Grendelmeier P
    Diabetes Care; 2012 Jun; 35(6):e41. PubMed ID: 22619293
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin allergy resolution following pancreas transplantation alone.
    Oh HK; Provenzano R; Hendrix J; el-Nachef MW
    Clin Transplant; 1998 Dec; 12(6):593-5. PubMed ID: 9850458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Insulin allergy: background, diagnosis and treatment].
    Wonders J; Eekhoff EM; Heine R; Bruynzeel DP; Rustemeyer T
    Ned Tijdschr Geneeskd; 2005 Dec; 149(50):2783-8. PubMed ID: 16385830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of alemtuzumab vs. anti-thymocyte globulin induction in renal and pancreas transplantation.
    Farney A; Sundberg A; Moore P; Hartmann E; Rogers J; Doares W; Jarrett A; Adams P; Stratta R
    Clin Transplant; 2008; 22(1):41-9. PubMed ID: 18217904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin allergy in a 19-month-old boy with newly diagnosed diabetes mellitus.
    Wishner KL; Fisher LK; Kumar D
    Pediatrics; 1982 Jul; 70(1):137-8. PubMed ID: 7045803
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure of multiple therapies in the treatment of a type 1 diabetic patient with insulin allergy: a case report.
    Koroscil T; Kagzi Y; Zacharias D
    Endocr Pract; 2011; 17(1):91-4. PubMed ID: 20713334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of allergy to monocomponent porcine and bovine insulin with monocomponent human insulin].
    Bruni B; Campana M; Carlini M; Gamba Ansaldi S; Grassi G; Regis G; Turco GL
    Minerva Endocrinol; 1984; 9(2):173-9. PubMed ID: 6390132
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperpigmentation due to insulin allergy.
    Neki NS; Gupta SN; Mani T; Gupta H
    Natl Med J India; 2014; 27(3):183. PubMed ID: 25668097
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin allergy and insulin resistance.
    Goldfine AB; Kahn CR
    Curr Ther Endocrinol Metab; 1994; 5():461-4. PubMed ID: 7704774
    [No Abstract]   [Full Text] [Related]  

  • 13. Pancreas transplantation: experience at University of Texas, Houston.
    Cicero A; Lappin JA
    Transplant Proc; 2010; 42(1):314-6. PubMed ID: 20172339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of insulin allergy and resistance.
    Elenbaas RM; Forni PJ
    Am J Hosp Pharm; 1976 May; 33(5):491-7. PubMed ID: 1274964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreas transplantation for treatment of generalized allergy to human insulin in type 1 diabetes.
    Malaise J; Leonet J; Goffin E; Lefebvre C; Tennstedt D; Vandeleene B; Buysschaert M; Squifflet JP
    Transplant Proc; 2005; 37(6):2839. PubMed ID: 16182826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From allergy to anti-IgE: targeting the cause.
    Oldani V
    Monaldi Arch Chest Dis; 2002 Apr; 57(2):115-6. PubMed ID: 12357839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No induction versus anti-IL2R induction therapy in simultaneous kidney pancreas transplantation: a comparative analysis.
    Becker LE; Nogueira VA; Abensur H; Miranda MP; Genzini T; Romão JE; Noronha IL
    Transplant Proc; 2006; 38(6):1933-6. PubMed ID: 16908327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective unresponsiveness to beta cell autoantigens after induction immunosuppression in pancreas transplantation with anti-interleukin-2 receptor antibody versus anti-thymocyte globulin.
    van de Linde P; Vd Boog PJ; Tysma OM; Elliott JF; Roelen DL; Claas FH; de Fijter JW; Roep BO
    Clin Exp Immunol; 2007 Jul; 149(1):56-62. PubMed ID: 17459076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desensitization-resistant insulin allergy.
    Frigerio C; Aubry M; Gomez F; Graf L; Dayer E; de Kalbermatten N; Gaillard RC; Spertini F
    Allergy; 1997 Feb; 52(2):238-9. PubMed ID: 9105538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.